You are now leaving a non-prescription product website and entering a prescription only product website.
The first and only topical scar product clinically proven to minimize the appearance of scars
Carlsbad, CA – May 30, 2012 – SkinMedica, Inc., the fastest-growing skin care brand for six consecutive years, introduces a first-of-its-kind treatment to help minimize the appearance of scars. SkinMedica Scar Recovery Gel with Centelline™ is the first topical scar product that supports the scar formation process and works from beginning to end to help smooth and minimize the appearance of scars.
“The clinically-proven efficacy of SkinMedica Scar Recovery Gel is a major step forward in providing a much-needed treatment option for scar diminishment,” said Dr. Alan Widgerow, FACS, who helped develop this product. “There’s currently a need for effective scar treatment options on the market, although it is a common concern for patients. As opposed to the multimodal action of Scar Recovery Gel, most other topical products available address only one or two phases of scar formation, or do not boast the clinical support.”
Designed for newer scars, this revolutionary formula features Centelline, a proprietary blend of naturally-derived specialty ingredients that leave scars less pronounced.
In one clinical study of 60 subjects who received small incisions from various plastic surgery procedures, 80% of those using Scar Recovery Gel demonstrated the best possible scar resolution (to Grade 1) in as little as 6 months compared to 13% of those receiving no treatment. In another study of 30 patients who received large incisions, 80% of those using of Scar Recovery Gel along with an adhesive tape demonstrated scar resolution to Grade 1 as compared to only 20% of those using adhesive tape alone.
“Scar Recovery Gel is another example of our innovative approach to skin care,” said Ted Schwarz, SkinMedica President. “It is a first-of-its-kind product that combines naturally-derived ingredients with scientific innovation to improve patient outcomes.”
SkinMedica Scar Recovery Gel is available for $95 beginning in May 2012 through a network of licensed physicians and medically supervised spas. Visit www.SkinMedica.com for locations.
SkinMedica, Inc. is focused on developing, acquiring, and commercializing products that improve the appearance of skin. SkinMedica markets and sells to physicians, with a focus on aesthetics, both prescription and non-prescription skin care products. The company's full line of aesthetic skin care products includes the revolutionary TNS Essential Serum® and hallmark TNS Recovery Complex®. The formulations in SkinMedica’s clinical skin care collection enhance skin appearance, reduce signs of aging, and provide other skin care benefits. SkinMedica's primary prescription product, VANIQA® (eflornithine hydrochloride) Cream 13.9%, is the only FDA-approved prescription product for the reduction of unwanted facial hair in women. Colorescience Pro’s dermatologist recommended, high-performance cosmetics are formulated to remedy and camouflage specific skin concerns and protect skin from damaging effects of the sun and environment. Colorescience Pro’s luxury aesthetic makeup line is sold in the physician and medical spa channels.
TNS Recovery Complex®, VANIQA®, and SkinMedica®, are registered trademarks of SkinMedica, Inc and affiliates.